InterCure Ltd (INCR) is lower by Monday morning, with the stock declining -7.14% in pre-market trading to 1.43. INCR's short-term technical score of 6 indicates that the stock has traded less bullishly over the last month than 94% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 125 out of 146 industries, the stock ranks higher than 14% of stocks. InterCure Ltd has fallen 8.33% over the past month, closing at $1.70 on September 11. During this period of time, the stock fell as low as $1.50 and as high as $1.76. INCR has an average analyst recommendation of Strong Buy. The company has an average price target of $5.00.
INCR has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on INCR!